Affinity-optimized TROP2 antibodies support potent antitumor activity in antibody-drug conjugates
{{output}}
Background: Trophoblast cell surface antigen 2 (TROP2) is frequently overexpressed in epithelial tumors and is associated with poor prognosis, making it an attractive therapeutic target. Antibody-drug conjugates (ADCs) directed a... ...
